[Recent developments in the treatment of tuberculosis].
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use*; D006801:Humans; D012293:Rifampin / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D013828:Thioacetazone / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D004977:Ethambutol; D013828:Thioacetazone; D012293:Rifampin; D013307:Streptomycin
Acquisitions récentes dans le traitement de la tuberculose.